ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Clomid for PCT, fertility or low T
EXTENDED-RELEASE FORMULATIONS OF HUMAN CHORIONIC GONADOTROPIN (HCG)
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 238300" data-attributes="member: 13851"><p><strong>*</strong><em><strong>In this valorization project, the Groningen consortium, which consists of InnoCore Pharmaceuticals and PolyVation, <u>will further develop and evaluate an innovative new drug, AndroSphere™, in a 'First-in-Man' phase 1 clinical trial</u>.</strong> <strong><u>AndroSphere™ is a long-acting injectable drug designed specifically for the treatment of hypogonadotropic hypogonadism (HH)</u>, a condition that leads to insufficient testosterone production in men. Low testosterone causes symptoms that limit their daily lives, such as severe fatigue, depression, anemia, and sexual dysfunction</strong></em></p><p><em><strong></strong></em></p><p><em><strong>*<strong><em>Using InnoCore's long-acting injectable microsphere technology based on biodegradable SynBiosys polymers, which will be produced by PolyVation, <u>AndroSphere™ is able to release hCG in a sustained and controlled manner, requiring only a single injection per month</u>. In addition, the encapsulation of the protein in the biodegradable polymeric microspheres increases the stability of hCG, making the therapy suitable for home use and self-administration reducing the need for a single injection per month</em></strong></strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 238300, member: 13851"] [B]*[/B][I][B]In this valorization project, the Groningen consortium, which consists of InnoCore Pharmaceuticals and PolyVation, [U]will further develop and evaluate an innovative new drug, AndroSphere™, in a 'First-in-Man' phase 1 clinical trial[/U].[/B] [B][U]AndroSphere™ is a long-acting injectable drug designed specifically for the treatment of hypogonadotropic hypogonadism (HH)[/U], a condition that leads to insufficient testosterone production in men. Low testosterone causes symptoms that limit their daily lives, such as severe fatigue, depression, anemia, and sexual dysfunction *[B][I]Using InnoCore's long-acting injectable microsphere technology based on biodegradable SynBiosys polymers, which will be produced by PolyVation, [U]AndroSphere™ is able to release hCG in a sustained and controlled manner, requiring only a single injection per month[/U]. In addition, the encapsulation of the protein in the biodegradable polymeric microspheres increases the stability of hCG, making the therapy suitable for home use and self-administration reducing the need for a single injection per month[/I][/B][/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Clomid for PCT, fertility or low T
EXTENDED-RELEASE FORMULATIONS OF HUMAN CHORIONIC GONADOTROPIN (HCG)
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top